8-K: Glucotrack Stockholders Fail to Reach Quorum

Glucotrack, Inc.'s special meeting of stockholders was permanently adjourned due to a persistent lack of quorum, preventing any business from being conducted.

Summary

• Glucotrack, Inc. (the Company) convened a special meeting of stockholders (the Meeting) on October 31, 2025, which was initially adjourned due to the absence of a quorum.
• The Meeting reconvened on November 7, 2025.
• As of the record date, September 23, 2025, there were 158,370 shares of common stock outstanding and entitled to vote.
• Only 17.6% of the eligible shares were represented at the reconvened meeting, which did not constitute a quorum under the Company's bylaws.
• Consequently, the Meeting was permanently adjourned and cancelled, and no business was conducted.

Sentiment

Score: 3

Explanation: The inability to conduct a shareholder meeting due to lack of quorum is a negative indicator for corporate governance and shareholder engagement, potentially signaling investor apathy or disagreement with proposed matters.

Negatives

• The special meeting of stockholders failed to achieve a quorum, preventing any business from being conducted.
• Low shareholder engagement was observed, with only 17.6% of shares represented at the reconvened meeting.
• The permanent adjournment and cancellation of the meeting means that the intended business could not be addressed.

Risks

• Risk to corporate governance due to the inability to conduct shareholder-approved business.
• Potential for delayed decision-making on matters intended for the special meeting.
• Indication of low shareholder engagement or potential investor apathy/dissatisfaction.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Management Comments

• Paul Goode, Chief Executive Officer, signed the report on behalf of Glucotrack, Inc.

Industry Context

This event is specific to Glucotrack's internal corporate governance and shareholder engagement. It does not directly reflect broader industry trends but highlights a challenge in securing sufficient shareholder participation that can affect any publicly traded company.

Corporate Governance

Stakeholder Impact

• Shareholders: Unable to vote on matters intended for the special meeting, potentially delaying decisions that affect their investment.
• Management: Unable to proceed with corporate actions requiring shareholder approval, potentially impacting strategic execution.

Next Steps

• No specific next steps related to the business of this particular meeting are mentioned, as it was permanently cancelled. The company will need to consider alternative ways to address the matters intended for this meeting.

Key Dates

Recommendation

The failure to achieve a quorum for a special meeting is a negative signal regarding corporate governance and shareholder engagement. While not directly impacting financial performance, it suggests potential difficulties in gaining shareholder consensus for future initiatives. Investors should hold and monitor for further communication regarding the matters intended for this meeting and any subsequent attempts to address them.

Keywords

Glucotrack, GCTK, SEC filing, 8-K, special meeting, stockholder meeting, quorum, corporate governance, shareholder vote, adjournment, Nasdaq